Global Pharmacovigilance Market Size, Status and Forecast 2021-2027

Q: How big is the Pharmacovigilance Market?

Ans: The global Pharmacovigilance market size is projected to reach US$ 7778 million by 2027, from US$ 4385.7 million in 2020, at a CAGR of 8.1% during 2021-2027.

Q: Who are the key companies available in the Pharmacovigilance industry?

Ans: Some of the major key companies are Eli Lilly and Company, ICON, Elsevier, Chiltern, Atlantic Research Group, Mapi Group, GSK, Accenture, Clinquest Group, PRA Health Sciences.

Q: Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

Q: What are the major factors that drives the growth of Pharmacovigilance market?

Ans. The rising rate of Adverse Drug Reactions (ADR) is a major driver for the growth of the pharmacovigilance market. ADR is one of the leading causes of morbidity in affluent countries, putting a significant strain on healthcare systems.

Code: QYRE-Auto-13S3239

Report

July 2021

108 Pages

QYResearch

Region: Global, North America, Southeast Asia, India, Europe, Central & South America

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly and Company

ICON

Elsevier

Chiltern

Atlantic Research Group

PRA Health Sciences, Inc.

Clinquest Group

PRA Health Sciences

Pharmacovigilance Market Overview 2027

The global Pharmacovigilance market size is projected to reach US$ 7778 million by 2027, from US$ 4385.7 million in 2020, at a CAGR of 8.1% during 2021-2027.

Pharmacovigilance Market Trends

Pharmacovigilance (PV) software comprises a drug safety management software solution that enables to creation, classification, review, submission, and maintain pharmacovigilance data and adverse event reports. This PV software is used by pharma and biotech companies, contract research organizations (CROs), business process outsourcing firms (BPOs), and other pharmacovigilance service providers.

pharmacovigilance market size

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacovigilance market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacovigilance market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacovigilance market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacovigilance market.

Pharmacovigilance market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Pharmacovigilance Market Segmentation

Segment by Type

Chemotherapy
Contract Outsourcing

Segment by Application

Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Others

By Region

North America
US.
Canada
Europe
Germany
France
UK.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Companies

Eli Lilly and Company
ICON
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture
Clinquest Group
GSK
PRA Health Sciences.

Scope of Pharmacovigilance Market Report

Report Metric	Details
Report Name	Pharmacovigilance Market
The market size in 2020	US$ 4385.7 million
The revenue forecast in 2027	US$ 7778 million
Growth Rate	CAGR of 8.1%
Market size available for years	2021-2027
Forecast units	Value (USD)
Segments covered	Type, Application, Industry, Regions
Report coverage	Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Geographic regions covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How big is the Pharmacovigilance Market?

Ans: The global Pharmacovigilance market size is projected to reach US$ 7778 million by 2027, from US$ 4385.7 million in 2020, at a CAGR of 8.1% during 2021-2027.

2. Who are the key companies available in the Pharmacovigilance industry?

Ans: Some of the major key companies are Eli Lilly and Company, ICON, Elsevier, Chiltern, Atlantic Research Group, Mapi Group, GSK, Accenture, Clinquest Group, PRA Health Sciences.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

4. What are the major factors that drives the growth of Pharmacovigilance market?

Ans. The rising rate of Adverse Drug Reactions (ADR) is a major driver for the growth of the pharmacovigilance market. ADR is one of the leading causes of morbidity in affluent countries, putting a significant strain on healthcare systems.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacovigilance Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Chemotherapy

1.2.3 Contract Outsourcing

1.3 Market by Application

1.3.1 Global Pharmacovigilance Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Pharma and Biotech Companies

1.3.3 Contract Research Organizations (CROs)

1.3.4 Business Process Outsourcing (BPO) Firms

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Pharmacovigilance Market Perspective (2016-2027)

2.2 Pharmacovigilance Growth Trends by Regions

2.2.1 Pharmacovigilance Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Pharmacovigilance Historic Market Share by Regions (2016-2021)

2.2.3 Pharmacovigilance Forecasted Market Size by Regions (2022-2027)

2.3 Pharmacovigilance Industry Dynamic

2.3.1 Pharmacovigilance Market Trends

2.3.2 Pharmacovigilance Market Drivers

2.3.3 Pharmacovigilance Market Challenges

2.3.4 Pharmacovigilance Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmacovigilance Players by Revenue

3.1.1 Global Top Pharmacovigilance Players by Revenue (2016-2021)

3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2016-2021)

3.2 Global Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Pharmacovigilance Revenue

3.4 Global Pharmacovigilance Market Concentration Ratio

3.4.1 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Revenue in 2020

3.5 Pharmacovigilance Key Players Head office and Area Served

3.6 Key Players Pharmacovigilance Product Solution and Service

3.7 Date of Enter into Pharmacovigilance Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacovigilance Breakdown Data by Type

4.1 Global Pharmacovigilance Historic Market Size by Type (2016-2021)

4.2 Global Pharmacovigilance Forecasted Market Size by Type (2022-2027)

5 Pharmacovigilance Breakdown Data by Application

5.1 Global Pharmacovigilance Historic Market Size by Application (2016-2021)

5.2 Global Pharmacovigilance Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Pharmacovigilance Market Size (2016-2027)

6.2 North America Pharmacovigilance Market Size by Type

6.2.1 North America Pharmacovigilance Market Size by Type (2016-2021)

6.2.2 North America Pharmacovigilance Market Size by Type (2022-2027)

6.2.3 North America Pharmacovigilance Market Size by Type (2016-2027)

6.3 North America Pharmacovigilance Market Size by Application

6.3.1 North America Pharmacovigilance Market Size by Application (2016-2021)

6.3.2 North America Pharmacovigilance Market Size by Application (2022-2027)

6.3.3 North America Pharmacovigilance Market Size by Application (2016-2027)

6.4 North America Pharmacovigilance Market Size by Country

6.4.1 North America Pharmacovigilance Market Size by Country (2016-2021)

6.4.2 North America Pharmacovigilance Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Pharmacovigilance Market Size (2016-2027)

7.2 Europe Pharmacovigilance Market Size by Type

7.2.1 Europe Pharmacovigilance Market Size by Type (2016-2021)

7.2.2 Europe Pharmacovigilance Market Size by Type (2022-2027)

7.2.3 Europe Pharmacovigilance Market Size by Type (2016-2027)

7.3 Europe Pharmacovigilance Market Size by Application

7.3.1 Europe Pharmacovigilance Market Size by Application (2016-2021)

7.3.2 Europe Pharmacovigilance Market Size by Application (2022-2027)

7.3.3 Europe Pharmacovigilance Market Size by Application (2016-2027)

7.4 Europe Pharmacovigilance Market Size by Country

7.4.1 Europe Pharmacovigilance Market Size by Country (2016-2021)

7.4.2 Europe Pharmacovigilance Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8 Asia-Pacific

8.1 Asia-Pacific Pharmacovigilance Market Size (2016-2027)

8.2 Asia-Pacific Pharmacovigilance Market Size by Type

8.2.1 Asia-Pacific Pharmacovigilance Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Pharmacovigilance Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Pharmacovigilance Market Size by Type (2016-2027)

8.3 Asia-Pacific Pharmacovigilance Market Size by Application

8.3.1 Asia-Pacific Pharmacovigilance Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Pharmacovigilance Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Pharmacovigilance Market Size by Application (2016-2027)

8.4 Asia-Pacific Pharmacovigilance Market Size by Region

8.4.1 Asia-Pacific Pharmacovigilance Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Pharmacovigilance Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Pharmacovigilance Market Size (2016-2027)

9.2 Latin America Pharmacovigilance Market Size by Type

9.2.1 Latin America Pharmacovigilance Market Size by Type (2016-2021)

9.2.2 Latin America Pharmacovigilance Market Size by Type (2022-2027)

9.2.3 Latin America Pharmacovigilance Market Size by Type (2016-2027)

9.3 Latin America Pharmacovigilance Market Size by Application

9.3.1 Latin America Pharmacovigilance Market Size by Application (2016-2021)

9.3.2 Latin America Pharmacovigilance Market Size by Application (2022-2027)

9.3.3 Latin America Pharmacovigilance Market Size by Application (2016-2027)

9.4 Latin America Pharmacovigilance Market Size by Country

9.4.1 Latin America Pharmacovigilance Market Size by Country (2016-2021)

9.4.2 Latin America Pharmacovigilance Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmacovigilance Market Size (2016-2027)

10.2 Middle East & Africa Pharmacovigilance Market Size by Type

10.2.1 Middle East & Africa Pharmacovigilance Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Pharmacovigilance Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Pharmacovigilance Market Size by Type (2016-2027)

10.3 Middle East & Africa Pharmacovigilance Market Size by Application

10.3.1 Middle East & Africa Pharmacovigilance Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Pharmacovigilance Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Pharmacovigilance Market Size by Application (2016-2027)

10.4 Middle East & Africa Pharmacovigilance Market Size by Country

10.4.1 Middle East & Africa Pharmacovigilance Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Pharmacovigilance Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Eli Lilly and Company

11.1.1 Eli Lilly and Company Company Details

11.1.2 Eli Lilly and Company Business Overview

11.1.3 Eli Lilly and Company Pharmacovigilance Introduction

11.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2016-2021)

11.1.5 Eli Lilly and Company Recent Development

11.2 ICON

11.2.1 ICON Company Details

11.2.2 ICON Business Overview

11.2.3 ICON Pharmacovigilance Introduction

11.2.4 ICON Revenue in Pharmacovigilance Business (2016-2021)

11.2.5 ICON Recent Development

11.3 Elsevier

11.3.1 Elsevier Company Details

11.3.2 Elsevier Business Overview

11.3.3 Elsevier Pharmacovigilance Introduction

11.3.4 Elsevier Revenue in Pharmacovigilance Business (2016-2021)

11.3.5 Elsevier Recent Development

11.4 Chiltern

11.4.1 Chiltern Company Details

11.4.2 Chiltern Business Overview

11.4.3 Chiltern Pharmacovigilance Introduction

11.4.4 Chiltern Revenue in Pharmacovigilance Business (2016-2021)

11.4.5 Chiltern Recent Development

11.5 Atlantic Research Group

11.5.1 Atlantic Research Group Company Details

11.5.2 Atlantic Research Group Business Overview

11.5.3 Atlantic Research Group Pharmacovigilance Introduction

11.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2016-2021)

11.5.5 Atlantic Research Group Recent Development

11.6 Mapi Group

11.6.1 Mapi Group Company Details

11.6.2 Mapi Group Business Overview

11.6.3 Mapi Group Pharmacovigilance Introduction

11.6.4 Mapi Group Revenue in Pharmacovigilance Business (2016-2021)

11.6.5 Mapi Group Recent Development

11.7 Accenture

11.7.1 Accenture Company Details

11.7.2 Accenture Business Overview

11.7.3 Accenture Pharmacovigilance Introduction

11.7.4 Accenture Revenue in Pharmacovigilance Business (2016-2021)

11.7.5 Accenture Recent Development

11.8 Clinquest Group

11.8.1 Clinquest Group Company Details

11.8.2 Clinquest Group Business Overview

11.8.3 Clinquest Group Pharmacovigilance Introduction

11.8.4 Clinquest Group Revenue in Pharmacovigilance Business (2016-2021)

11.8.5 Clinquest Group Recent Development

11.9 GSK

11.9.1 GSK Company Details

11.9.2 GSK Business Overview

11.9.3 GSK Pharmacovigilance Introduction

11.9.4 GSK Revenue in Pharmacovigilance Business (2016-2021)

11.9.5 GSK Recent Development

11.10 PRA Health Sciences

11.10.1 PRA Health Sciences Company Details

11.10.2 PRA Health Sciences Business Overview

11.10.3 PRA Health Sciences Pharmacovigilance Introduction

11.10.4 PRA Health Sciences Revenue in Pharmacovigilance Business (2016-2021)

11.10.5 PRA Health Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly and Company

ICON

Elsevier

Chiltern

Atlantic Research Group

PRA Health Sciences, Inc.

Clinquest Group

PRA Health Sciences

List of Tables

Table 1. Global Pharmacovigilance Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of Chemotherapy

Table 3. Key Players of Contract Outsourcing

Table 4. Global Pharmacovigilance Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 5. Global Pharmacovigilance Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 6. Global Pharmacovigilance Market Size by Regions (2016-2021) & (US$ Million)

Table 7. Global Pharmacovigilance Market Share by Regions (2016-2021)

Table 8. Global Pharmacovigilance Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 9. Global Pharmacovigilance Market Share by Regions (2022-2027)

Table 10. Pharmacovigilance Market Trends

Table 11. Pharmacovigilance Market Drivers

Table 12. Pharmacovigilance Market Challenges

Table 13. Pharmacovigilance Market Restraints

Table 14. Global Pharmacovigilance Revenue by Players (2016-2021) & (US$ Million)

Table 15. Global Pharmacovigilance Market Share by Players (2016-2021)

Table 16. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2020)

Table 17. Ranking of Global Top Pharmacovigilance Companies by Revenue (US$ Million) in 2020

Table 18. Global 5 Largest Players Market Share by Pharmacovigilance Revenue (CR5 and HHI) & (2016-2021)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Pharmacovigilance Product Solution and Service

Table 21. Date of Enter into Pharmacovigilance Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)

Table 24. Global Pharmacovigilance Revenue Market Share by Type (2016-2021)

Table 25. Global Pharmacovigilance Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 26. Global Pharmacovigilance Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 27. Global Pharmacovigilance Market Size Share by Application (2016-2021) & (US$ Million)

Table 28. Global Pharmacovigilance Revenue Market Share by Application (2016-2021)

Table 29. Global Pharmacovigilance Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 30. Global Pharmacovigilance Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 31. North America Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)

Table 32. North America Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)

Table 33. North America Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)

Table 34. North America Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)

Table 35. North America Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)

Table 36. North America Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)

Table 37. Europe Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)

Table 38. Europe Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)

Table 39. Europe Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)

Table 40. Europe Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)

Table 41. Europe Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)

Table 42. Europe Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)

Table 43. Asia-Pacific Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)

Table 44. Asia-Pacific Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)

Table 45. Asia-Pacific Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)

Table 46. Asia-Pacific Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)

Table 47. Asia-Pacific Pharmacovigilance Market Size by Region (2016-2021) & (US$ Million)

Table 48. Asia-Pacific Pharmacovigilance Market Size by Region (2022-2027) & (US$ Million)

Table 49. Latin America Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)

Table 50. Latin America Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)

Table 51. Latin America Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)

Table 52. Latin America Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)

Table 53. Latin America Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)

Table 54. Latin America Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)

Table 55. Middle East & Africa Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)

Table 56. Middle East & Africa Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)

Table 57. Middle East & Africa Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)

Table 58. Middle East & Africa Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)

Table 59. Middle East & Africa Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)

Table 60. Middle East & Africa Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)

Table 61. Eli Lilly and Company Company Details

Table 62. Eli Lilly and Company Business Overview

Table 63. Eli Lilly and Company Pharmacovigilance Product

Table 64. Eli Lilly and Company Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 65. Eli Lilly and Company Recent Development

Table 66. ICON Company Details

Table 67. ICON Business Overview

Table 68. ICON Pharmacovigilance Product

Table 69. ICON Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 70. ICON Recent Development

Table 71. Elsevier Company Details

Table 72. Elsevier Business Overview

Table 73. Elsevier Pharmacovigilance Product

Table 74. Elsevier Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 75. Elsevier Recent Development

Table 76. Chiltern Company Details

Table 77. Chiltern Business Overview

Table 78. Chiltern Pharmacovigilance Product

Table 79. Chiltern Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 80. Chiltern Recent Development

Table 81. Atlantic Research Group Company Details

Table 82. Atlantic Research Group Business Overview

Table 83. Atlantic Research Group Pharmacovigilance Product

Table 84. Atlantic Research Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 85. Atlantic Research Group Recent Development

Table 86. Mapi Group Company Details

Table 87. Mapi Group Business Overview

Table 88. Mapi Group Pharmacovigilance Product

Table 89. Mapi Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 90. Mapi Group Recent Development

Table 91. Accenture Company Details

Table 92. Accenture Business Overview

Table 93. Accenture Pharmacovigilance Product

Table 94. Accenture Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 95. Accenture Recent Development

Table 96. Clinquest Group Company Details

Table 97. Clinquest Group Business Overview

Table 98. Clinquest Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 99. Clinquest Group Recent Development

Table 100. GSK Company Details

Table 101. GSK Business Overview

Table 102. GSK Pharmacovigilance Product

Table 103. GSK Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 104. GSK Recent Development

Table 105. PRA Health Sciences Company Details

Table 106. PRA Health Sciences Business Overview

Table 107. PRA Health Sciences Pharmacovigilance Product

Table 108. PRA Health Sciences Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)

Table 109. PRA Health Sciences Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmacovigilance Market Share by Type: 2020 VS 2027

Figure 2. Chemotherapy Features

Figure 3. Contract Outsourcing Features

Figure 4. Global Pharmacovigilance Market Share by Application: 2020 VS 2027

Figure 5. Pharma and Biotech Companies Case Studies

Figure 6. Contract Research Organizations (CROs) Case Studies

Figure 7. Business Process Outsourcing (BPO) Firms Case Studies

Figure 8. Others Case Studies

Figure 9. Pharmacovigilance Report Years Considered

Figure 10. Global Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 11. Global Pharmacovigilance Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 12. Global Pharmacovigilance Market Share by Regions: 2020 VS 2027

Figure 13. Global Pharmacovigilance Market Share by Regions (2022-2027)

Figure 14. Global Pharmacovigilance Market Share by Players in 2020

Figure 15. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2020

Figure 16. The Top 10 and 5 Players Market Share by Pharmacovigilance Revenue in 2020

Figure 17. Global Pharmacovigilance Revenue Market Share by Type (2016-2021)

Figure 18. Global Pharmacovigilance Revenue Market Share by Type (2022-2027)

Figure 19. North America Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 20. North America Pharmacovigilance Market Share by Type (2016-2027)

Figure 21. North America Pharmacovigilance Market Share by Application (2016-2027)

Figure 22. North America Pharmacovigilance Market Share by Country (2016-2027)

Figure 23. United States Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 24. Canada Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 25. Europe Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 26. Europe Pharmacovigilance Market Share by Type (2016-2027)

Figure 27. Europe Pharmacovigilance Market Share by Application (2016-2027)

Figure 28. Europe Pharmacovigilance Market Share by Country (2016-2027)

Figure 29. Germany Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 30. France Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. U.K. Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 32. Italy Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 33. Russia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 34. Nordic Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 35. Asia-Pacific Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 36. Asia-Pacific Pharmacovigilance Market Share by Type (2016-2027)

Figure 37. Asia-Pacific Pharmacovigilance Market Share by Application (2016-2027)

Figure 38. Asia-Pacific Pharmacovigilance Market Share by Region (2016-2027)

Figure 39. China Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 40. Japan Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. South Korea Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 42. Southeast Asia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 43. India Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 44. Australia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 45. Latin America Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 46. Latin America Pharmacovigilance Market Share by Type (2016-2027)

Figure 47. Latin America Pharmacovigilance Market Share by Application (2016-2027)

Figure 48. Latin America Pharmacovigilance Market Share by Country (2016-2027)

Figure 49. Mexico Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 50. Brazil Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Middle East & Africa Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 52. Middle East & Africa Pharmacovigilance Market Share by Type (2016-2027)

Figure 53. Middle East & Africa Pharmacovigilance Market Share by Application (2016-2027)

Figure 54. Middle East & Africa Pharmacovigilance Market Share by Country (2016-2027)

Figure 55. Turkey Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 56. Saudi Arabia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. UAE Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 58. Eli Lilly and Company Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 59. ICON Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 60. Elsevier Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 61. Chiltern Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 62. Atlantic Research Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 63. Mapi Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 64. Accenture Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 65. Clinquest Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 66. GSK Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 67. PRA Health Sciences Revenue Growth Rate in Pharmacovigilance Business (2016-2021)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pharmacovigilance Outsourcing Market

CRO Market

Pharmacovigilance Software Market

Drug Safety Solutions and Pharmacovigilance Market

Global Life Sciences Analytics Market Research Report 2023

Global Pharmacovigilance Outsourcing Market Research Report 2023

Global Pharmacovigilance System Market Research Report 2023

Global Pharmacovigilance (PV) Outsourcing Market Research Report 2023

Global Life Science Software Market Research Report 2023

Global Healthcare CRO Market Research Report 2023

Global The Contract Research (CRO) Market Research Report 2023

Global Drug Safety and Pharmacovigilance (PV) Software Market Research Report 2023

Global Veterinary CRO Market Research Report 2023

Global Pharmacovigilance (PV) and Drug Safety Software Market Research Report 2023

Global Contract Research Outsourcing Market Research Report 2023

Global CROs Services Market Research Report 2023

Global Clinical Research Digitization Market Research Report 2023

Global Clinical Development Services Market Research Report 2023

Global Pharmacovigilance Services Market Research Report 2023

Global AI In Telecommunication Market Size, Status and Forecast 2021-2027

Nutritional Analysis Market Size, Share & Trends Analysis Report By Type, By Application, and Segment Forecasts, 2021-2027

Digital PCR Market by Technologies (Droplet Digital PCR, Chip Based Digital PCR and BEAMing Digital PCR), Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), Application (Research, Clinical Diagnostics, and Forensic & Others), and End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities & Other Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2028

Global Power Semiconductor Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Lithium-Ion Battery Separator Market Insights and Forecast to 2028

Global Pharmacovigilance Market Size, Status and Forecast 2021-2027

Published Date: July 2021

Report Code: QYRE-Auto-13S3239

Global Pharmacovigilance Market Size, Status and Forecast 2021-2027

FEATURED COMPANIES

Pharmacovigilance Market Overview 2027

Pharmacovigilance Market Trends

Pharmacovigilance Market Segmentation

Scope of Pharmacovigilance Market Report

Frequently Asked Questions About This Report

1. How big is the Pharmacovigilance Market?

2. Who are the key companies available in the Pharmacovigilance industry?

3. Does the report provides covid-19 impact analysis?

4. What are the major factors that drives the growth of Pharmacovigilance market?

FEATURED COMPANIES

RELATED REPORTS